{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T03:13:52Z","timestamp":1769742832430,"version":"3.49.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pulmonary Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.pupt.2016.03.001","type":"journal-article","created":{"date-parts":[[2016,3,5]],"date-time":"2016-03-05T19:52:33Z","timestamp":1457207553000},"page":"73-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Pharmacological effects of lysozyme on COPD and bronchial asthma with sputum: A randomized, placebo-controlled, small cohort, cross-over study"],"prefix":"10.1016","volume":"37","author":[{"given":"Hiroyuki","family":"Ohbayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiro","family":"Setoguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshinosuke","family":"Fukuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukinori","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihisa","family":"Arai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pupt.2016.03.001_bib1","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1164\/ajrccm.153.5.8630597","article-title":"Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity","volume":"153","author":"Vestbo","year":"1996","journal-title":"Cph. City Heart Study Grp. Am. J. Respir. Crit. Care Med."},{"issue":"10","key":"10.1016\/j.pupt.2016.03.001_bib2","first-page":"955","article-title":"Clinical effects of carbocisteine on exacerbation in patients with COPD (PEACE study)","volume":"26","author":"Fukuchi","year":"2007","journal-title":"KoKyu"},{"key":"10.1016\/j.pupt.2016.03.001_bib3","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/S0140-6736(08)60869-7","article-title":"Effect of carbocisteine on acute exacerbation of chronic obstructive pulmonary disease (PEACE study): a randomised placebo-controlled study","volume":"371","author":"Zheng","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2016.03.001_bib4","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(05)66456-2","article-title":"Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (bronchitis randomized on NAC cost-utility study, BRONCUS): a randomized placebo-controlled trial","volume":"365","author":"Decramer","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.pupt.2016.03.001_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pupt.2003.08.004","article-title":"Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST trail)","volume":"17","author":"Malerba","year":"2004","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.pupt.2016.03.001_bib6","series-title":"Asthma Prevention and Management Guideline 2012, Japan","author":"Japanese Society of Allergology","year":"2012"},{"issue":"6","key":"10.1016\/j.pupt.2016.03.001_bib7","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1165\/rcmb.2005-0059OC","article-title":"Lysozyme secretion by submucosal glands protects the airway from bacterial infection","volume":"32","author":"Dajani","year":"2005","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.pupt.2016.03.001_bib8","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1172\/JCI115407","article-title":"Killing of gram-negative bacteria by lactoferrin and lysozyme","volume":"88","author":"Ellison","year":"1991","journal-title":"J.\u00a0Clin. Invest."},{"issue":"2","key":"10.1016\/j.pupt.2016.03.001_bib9","first-page":"148","article-title":"Lower respiratory tract lactoferrin and lysozyme arise primarily in the airways and are elevated in association with chronic bronchitis","volume":"115","author":"Thompson","year":"1990","journal-title":"J.\u00a0Lab. Clin. Med."},{"key":"10.1016\/j.pupt.2016.03.001_bib10","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1172\/JCI109443","article-title":"Modulation of neutrophil function by lysozyme. Potential negative feedback system of inflammation","volume":"64","author":"Gordon","year":"1979","journal-title":"J.\u00a0Clin. Invest."},{"issue":"9","key":"10.1016\/j.pupt.2016.03.001_bib11","first-page":"2347","article-title":"Effects of lysozyme chloride (Acdeam\u00ae) on foreign materials excretion by tracheal mucociliary transport","volume":"25","author":"Shimizu","year":"1997","journal-title":"Jpn. Pharmacol. Ther."},{"key":"10.1016\/j.pupt.2016.03.001_bib12","first-page":"701","article-title":"An experimental study in the influence of age various drugs on ciliary beat frequency","volume":"13","author":"Kayama","year":"1985","journal-title":"Jpn. Pharmacol. Ther."},{"key":"10.1016\/j.pupt.2016.03.001_bib13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.ejphar.2010.05.045","article-title":"Carbocisteine normalizes the viscous property of mucus through regulation of fucosylated and sialylated sugar chain on airway mucins","volume":"641","author":"Ishibashi","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pupt.2016.03.001_bib14","first-page":"5879","article-title":"Objective appraisal of the efficacy of lysozyme hydrochloride (neuzym tablet) as an expectorant","volume":"15","author":"Nagaoka","year":"1981","journal-title":"Clin. Rep."},{"issue":"2","key":"10.1016\/j.pupt.2016.03.001_bib15","first-page":"371","article-title":"The effect of the preparation of lysozyme hydrochloride on sputum","volume":"15","author":"Nagaoka","year":"1986","journal-title":"Ther. Res."},{"issue":"5","key":"10.1016\/j.pupt.2016.03.001_bib16","first-page":"581","article-title":"The study of lysozyme chloride on the relationship between the chances of symptoms and physiochemical properties of sputum in chronic pulmonary disease","volume":"53","author":"Tanaka","year":"2005","journal-title":"Jpn. J. Med. Pharm. Sci."},{"issue":"9","key":"10.1016\/j.pupt.2016.03.001_bib17","first-page":"708","article-title":"Therapeutic efficacy of lysozyme on the difficulty of expectoration","volume":"34","author":"Mitsui","year":"1975","journal-title":"Jpn. J. Chest Dis."},{"issue":"4","key":"10.1016\/j.pupt.2016.03.001_bib18","first-page":"827","article-title":"Clinical studies on chronic pulmonary disease \u2013 combination therapy with lysozyme chloride and ambroxol hydrochrolide","volume":"26","author":"Sato","year":"1991","journal-title":"Jpn. J. Med. Pharm. Sci."},{"issue":"7","key":"10.1016\/j.pupt.2016.03.001_bib19","first-page":"2629","article-title":"Clinical study on expectorant effect of ambroxol hydrochloride in chronic pulmonary diseases","volume":"20","author":"Kawada","year":"1992","journal-title":"Jpn. Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.pupt.2016.03.001_bib20","first-page":"1163","article-title":"Clinical effect of ambroxol (ponophen) on expectorantion in patients with chronic respiratory disease","volume":"21","author":"Nakajima","year":"1993","journal-title":"Jpn. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.pupt.2016.03.001_bib21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.pupt.2011.06.002","volume":"24","author":"Abe","year":"2011","journal-title":"Pulm. Pharmacol. Ther."},{"key":"10.1016\/j.pupt.2016.03.001_bib22","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1440-1681.2002.03605.x","article-title":"Concentration of egg white lysozyme in the serum of healthy subjects after oral administration","volume":"29","author":"Hashida","year":"2002","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"issue":"1","key":"10.1016\/j.pupt.2016.03.001_bib23","first-page":"109","article-title":"Phase III clinical study of SS320A \u2013double blind trial in comparison with pracebo","volume":"18","author":"Nagaoka","year":"2002","journal-title":"J.\u00a0Clin. Ther. Med."},{"issue":"3","key":"10.1016\/j.pupt.2016.03.001_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S2213-2600(14)70001-3","article-title":"Minimum clinically important difference for the COPD assessment test: a prospective analysis","volume":"2","author":"Kon","year":"2014","journal-title":"Lancet Respir. Med."},{"issue":"26","key":"10.1016\/j.pupt.2016.03.001_bib25","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1056\/NEJMoa032158","article-title":"The nature of small-airway obstruction in chronic obstructive pulmonary disease","volume":"350","author":"Hogg","year":"2004","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.pupt.2016.03.001_bib26","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.phrs.2004.07.006","article-title":"Effects of salmeterol on cilia and mucus in COPD and pneumonia patients","volume":"51","author":"Piatti","year":"2005","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pupt.2016.03.001_bib27","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMra0910061","article-title":"Airway mucus function and dysfunction","volume":"363","author":"Fahy","year":"2010","journal-title":"New Eng. J. Med."},{"key":"10.1016\/j.pupt.2016.03.001_bib28","first-page":"4165","article-title":"The anti-inflammatory effect of lysozyme hydrochloride on rabbits with different doses","volume":"14","author":"Naito","year":"1986","journal-title":"Jpn. Pharmacol. Ther."},{"key":"10.1016\/j.pupt.2016.03.001_bib29","first-page":"587","article-title":"Pharmacological effects of lysozyme and its reaction with serum proteins","volume":"21","author":"Fukawa","year":"1981","journal-title":"Pharmacometrics"},{"issue":"1","key":"10.1016\/j.pupt.2016.03.001_bib30","doi-asserted-by":"crossref","first-page":"126","DOI":"10.25004\/IJPSDR.2015.070124","article-title":"Lysozyme hydrochloride inhibits cytokines in epithelial cells with respiratory syncytial virus infection: a brief report","volume":"7","author":"Sakurai","year":"2015","journal-title":"Int. J. Pharm. Sci. Drug Res."},{"key":"10.1016\/j.pupt.2016.03.001_bib31","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1164\/ajrccm.162.2.9908132","article-title":"Increase in reacrive nitrogen species production in cronic obstructive pulmonary disease airways","volume":"162","author":"Ichinose","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2016.03.001_bib32","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2332\/allergolint.10-OA-0197","article-title":"Reference ranges for exhaled nitric oxide fraction in healthy Japanese adult population","volume":"59","author":"Matsunaga","year":"2010","journal-title":"Allergol. Int."},{"key":"10.1016\/j.pupt.2016.03.001_bib33","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2147\/COPD.S88274","article-title":"Biomarker-based detection of ashma-COPD overlap syndrome in COPD populations","volume":"10","author":"Tamada","year":"2015","journal-title":"Int. J. Chron. Obstr. Pulmon. Dis."},{"issue":"9","key":"10.1016\/j.pupt.2016.03.001_bib34","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1365-2362.2012.02686.x","article-title":"ECLIPSE investigators (evaluation of COPD longitudinally to identify predictive surrogate endpoints). Dysregulated adipokine metabolism in chronic obstructive pulmonary disease","volume":"42","author":"Breyer","year":"2012","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1016\/j.pupt.2016.03.001_bib35","article-title":"Controlled oral steroid intervention decreases serum periostin levels in asthmatic patients","volume":"187","author":"James","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.pupt.2016.03.001_bib36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.alit.2015.01.001","article-title":"Periostin in the bronchial lavage fluid of asthma patients","volume":"64","author":"Nakamura","year":"2015","journal-title":"Allergol. Int."}],"container-title":["Pulmonary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553916300116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1094553916300116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T17:01:54Z","timestamp":1748797314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1094553916300116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":36,"alternative-id":["S1094553916300116"],"URL":"https:\/\/doi.org\/10.1016\/j.pupt.2016.03.001","relation":{},"ISSN":["1094-5539"],"issn-type":[{"value":"1094-5539","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological effects of lysozyme on COPD and bronchial asthma with sputum: A randomized, placebo-controlled, small cohort, cross-over study","name":"articletitle","label":"Article Title"},{"value":"Pulmonary Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pupt.2016.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}